InventisBio

InventisBio

InventisBio

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Founded
2013
Raised
$236M
Follow us
Alexa global traffic share
Latest funding Show all
$147,000,000
Venture capital (Series D) - 2020
QiMing Venture Partners Ltd OrbiMed +8
$70,000,000
Venture capital (Series C) - 2019
OrbiMed Lilly Asia Ventures Advantech Capital +1
Team Size
1–10
Employees
Location
Headquarters
$147,000,000 Venture capital (Series D)
FinSMEs

InventisBio Raises $147M in Series D Financing

FinSMEs

InventisBio Closes $70 Million USD Series C Financing

$19,000,000 Venture capital (Series B)
ChinaMoneyNetwork , PE HUB , AVCJ

OrbiMed Asia Leads $19M Series B Round In Biotech Start-Up InventisBio

Funding Asia Health